688193 仁度生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.4940.8583.73625.70533.567
总资产报酬率 ROA (%)0.4540.7713.18018.74724.657
投入资产回报率 ROIC (%)0.4890.8443.63924.14831.911

边际利润分析
销售毛利率 (%)80.38981.38265.52974.62375.872
营业利润率 (%)3.4473.3109.05324.69627.664
息税前利润/营业总收入 (%)-0.896-2.0537.33324.27728.072
净利润/营业总收入 (%)3.5765.0247.67922.10724.560

收益指标分析
经营活动净收益/利润总额(%)-115.651-375.33150.14090.09290.158
价值变动净收益/利润总额(%)162.213159.27634.9351.6761.537
营业外收支净额/利润总额(%)-0.339-14.271-3.0940.3501.582

偿债能力分析
流动比率 (X)12.36911.46210.1884.2612.990
速动比率 (X)12.02011.0979.8923.9692.777
资产负债率 (%)7.7608.72011.69623.99930.810
带息债务/全部投入资本 (%)-0.101-0.095-1.251-3.6870.124
股东权益/带息债务 (%)-98,140.546-104,367.986-7,834.932-2,590.86174,087.456
股东权益/负债合计 (%)1,188.5841,046.754754.992316.691224.568
利息保障倍数 (X)0.2070.415-5.064-48.026-774.568

营运能力分析
应收账款周转天数 (天)147.712198.89394.89258.17643.138
存货周转天数 (天)278.183334.51281.93486.70680.759